At Davos industry leaders discussed the promise and pitfalls of precision medicine - Watch the video!
There’s endless talk about precision medicine. But what’s really moving the needle - and what’s limiting its potential- now and in the future?
Those were the questions that brought together a handful of high-profile names in biopharma for a panel discussion on 26 January 2018 at the final day of the World Economic Forum’s annual meeting in the Swiss resort town of Davos.
The lineup of panelists included Food and Drug Administration Commissioner - Scott Gottlieb, Illumina’s executive chairman - Jay Flatley, American Heart Association CEO - Nancy Brown, Singapore health official - Tan Chorh Chuan, and Vas Narasimhan, who officially becomes CEO of Novartis next week. The panel was moderated by Linda Pizzuti Henry, the managing director of Boston Globe Media Partners, which owns STAT.
The full video is available on the STAT website.
